Streptococcus Uberis BacterinThis page contains information on Streptococcus Uberis Bacterin for veterinary use.
The information provided typically includes the following:
- Streptococcus Uberis Bacterin Indications
- Warnings and cautions for Streptococcus Uberis Bacterin
- Direction and dosage information for Streptococcus Uberis Bacterin
Streptococcus Uberis BacterinThis treatment applies to the following species:
This product is intended for use in healthy adult dairy cattle (18 months and older) as an ad in the reduction of mastitis due to Streptococcus uberis. To use, shake well and administer a 5 cc dose subcutaneously. Three doses are recommended at four to six week intervals. Do not vaccinate within two weeks of parturition.
For veterinary use only. Do not vaccinate within 60 days of slaughter. Entire contents of this bottle should be used when first opened. If an anaphylactic reaction occurs, appropriate therapy with epinephrine or other anti-anaphylactic drugs should be instituted immediately. Any adverse reactions following vaccination should he reported to the manufacturer.
WarningThis product contains oil adjuvant. In the event of accidental self-injection, seek medical attention immediately. This product is conditionally licensed. Full efficacy and potency studies are in progress.
Keep refrigerated not over 45°F or 7°C. Do not freeze! SHAKE WELL BEFORE USING.
HYGIEIA BIOLOGICAL LABORATORIES, P.O. Box 8300, Woodland, CA 95776 USA
T: 530-661-1442 / F: 530-661-1633 / email@example.com
U.S. Veterinary License No. 407
Presentation: 10 dose (50 cc) and 50 dose (250 cc) bottles.
P.O. BOX 8300, WOODLAND, CA, 95776
|Lab/Main Office:||530-661-1442 (telephone)|
|Adverse Reaction Reporting:||530-661-1442 (telephone)|
|Every effort has been made to ensure the accuracy of the Streptococcus Uberis Bacterin information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2020 Animalytix LLC. Updated: 2020-10-21